Table 2 Sample characteristics
Sample characteristic | Value |
|---|---|
Total number of analyzed samples | 152 |
Obtained during PIPAC 1 (“untreated”) | 53 (34.9 %) |
Obtained during PIPAC ≥2 (“treated”) | 99 (65.1 %) |
Histologically assessed as | |
Tumor | 136 (89.5 %) |
With concurrent ascites | 88 (64.7 %) |
Without concurrent ascites | 48 (35.3 %) |
Tumor-free | 16 (10.5 %) |